NASDAQ:ALLO | Profit Breakdown | Allogene Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$4.64M-$46.92M-$42.68M
2026-03-31-$46.09M-$42.61M
2025-12-31$0.00-$42.4M-$38.81M
2025-09-30$0.00-$44.9M-$41.4M
2025-06-30$0.00-$56.82M-$50.94M
2025-03-31$0.00-$65.19M-$59.73M
2024-12-31$0.00-$60.49M-$59.94M
2024-09-30$0.00-$71.77M-$66.29M
2024-06-30$0.00-$71.43M-$66.36M
2024-03-31$22,000.00-$69.5M-$65M
2023-12-31$21,000.00-$85.11M-$85.78M
2023-09-30$22,000.00-$63M-$62.29M
2023-06-30$22,000.00-$80.54M-$79.23M
2023-03-31$30,000.00-$99.09M-$99.97M
2022-12-31$26,000.00-$96.4M-$97.28M
2022-09-30$49,000.00-$82.49M-$83.15M
2022-06-30$86,000.00-$76.59M-$74.79M
2022-03-31$61,000.00-$79.99M-$79.85M
2021-12-31$75.65M$1.71M$86,000.00
2021-09-30$49,000.00-$77.67M-$78.19M
2021-06-30$44,000.00-$71.03M-$70.94M
2021-03-31$38.35M-$33.2M-$33.02M
2020-12-31$0.00-$69.36M-$68.57M-$68.57M
2020-09-30$0.00-$68.04M-$66.2M-$66.2M
2020-06-30$0.00-$63.16M-$60.97M-$60.97M
2020-03-31$0.00-$57.68M-$54.48M-$54.48M
2019-12-31-$64.58M-$61.19M-$61.03M
2019-09-30-$55.01M-$50.7M-$50.74M
2019-06-30-$45.96M-$41.4M-$41.24M
2019-03-31-$36.46M-$31.64M-$31.59M
2018-12-31-$33.05M-$30.63M-$30.51M
2018-09-30-$22.19M-$43.5M-$43.5M
2018-06-30-$135.01M-$134.9M-$134.9M
2018-03-31-$2.6M-$2.6M-$2.6M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$209.32M-$190.89M-$190.89M
2024-12-31$22,000.00-$273.2M-$257.15M-$257.59M
2023-12-31$95,000.00-$327.74M-$327.27M-$327.27M
2022-12-31$156,000.00-$335.54M-$340.41M
2021-12-31$114.09M-$180.19M-$257.01M-$182.05M
2020-12-31$0.00-$258.24M-$250.22M-$250.22M
2019-12-31$0.00-$202.01M-$184.93M-$184.59M
2018-12-31-$192.84M-$211.62M-$211.51M